Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.2217/fmb-2021-0008 http://scihub22266oqcxt.onion/10.2217/fmb-2021-0008 34319168!8317972!34319168     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=34319168&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Future+Microbiol 2021 ; 16 (?): 919-925 Nephropedia Template TP {{tp|p=34319168|t=2021. Suboptimal antimicrobial stewardship in the COVID-19 era: is humanity staring at a postantibiotic future?|pdf=|usr=}}{{34319168}} gab.com Text Suboptimal antimicrobial stewardship in the COVID-19 era: is humanity staring at a postantibiotic future JO: Future Microbiol http://www.kidney.de/pget.php?&tw=1&pmid=34319168 #FOAvip In the absence of potent antimicrobial agents, it is estimated that bacterial infections could cause millions of deaths. The emergence of COVID-19, its complex pathophysiology and the high propensity of patients to coinfections has resulted in therapeutic regimes that use a cocktail of antibiotics for disease management. Suboptimal antimicrobial stewardship in this era and the slow pace of drug discovery could result in large-scale drug resistance, narrowing future antimicrobial therapeutics. Thus, judicious use of current antimicrobials is imperative to keep up with existing and emerging infectious pathogens. Here, we provide insights into the potential implications of suboptimal antimicrobial stewardship, resulting from the emergence of COVID-19, on the spread of antimicrobial resistance. Twit Text FOAVip Suboptimal antimicrobial stewardship in the COVID-19 era: is humanity staring at a postantibiotic future ????Future Microbiol http://www.kidney.de/pget.php?&tw=1&pmid=34319168 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34319168 #FOAvip English Wikipedia <ref>{{Cite pmid|34319168}}</ref> Suboptimal antimicrobial stewardship in the COVID-19 era: is humanity staring at a postantibiotic future? #MMPMID34319168 Owoicho O; Tapela K; Djomkam Zune AL; Nghochuzie NN; Isawumi A; Mosi L Future Microbiol 2021[Aug]; 16 (?): 919-925 PMID34319168show ga In the absence of potent antimicrobial agents, it is estimated that bacterial infections could cause millions of deaths. The emergence of COVID-19, its complex pathophysiology and the high propensity of patients to coinfections has resulted in therapeutic regimes that use a cocktail of antibiotics for disease management. Suboptimal antimicrobial stewardship in this era and the slow pace of drug discovery could result in large-scale drug resistance, narrowing future antimicrobial therapeutics. Thus, judicious use of current antimicrobials is imperative to keep up with existing and emerging infectious pathogens. Here, we provide insights into the potential implications of suboptimal antimicrobial stewardship, resulting from the emergence of COVID-19, on the spread of antimicrobial resistance. |*Bacterial Infections/drug therapy/epidemiology[MESH] |*Coinfection/drug therapy/epidemiology[MESH] |*Mycoses/drug therapy/epidemiology[MESH] |Anti-Infective Agents/therapeutic use[MESH] |Antimicrobial Stewardship/*methods[MESH] |COVID-19/*epidemiology[MESH] |Hand Disinfection[MESH]Suboptimal antimicrobial stewardship in the COVID-19 era: is humanity (epmc).pdf DeepDyve Pubget Overpricing